Skip to Content
COVID-19 Response and Update
International
  • About
        • AboutWe challenge convention so healthy can be possible for all
        • Our Story
          • Amneal at-a-glance
          • Our Founders
        • Our Purpose & Commitments
        • Our Culture
          • Rise, Lead, Succeed
        • Our Milestones
        • Leadership
          • Executive Leadership
          • Board of Directors
        • Locations
        • Responsibility
          • The Amneal Patient Assistance Program
          • Product Donations
          • National and Local Philanthropy
          • Compliance and Ethics
        • Awards & Recognition
  • Products
        • ProductsWe produce quality generic, specialty and biosimilar medicines
        • Our Portfolio
          • Generic Products
          • Specialty Products
          • Product Catalog
        • Quality
        • Drug Safety
          • Adverse Event Reporting
          • Medical Inquiries
          • Product Complaints
        • Operations
        • Amneal Products
  • Research & Development
        • Research & DevelopmentWe invest significantly in new product development
        • Generics R&D
        • Specialty R&D
          • Drug Delivery Technologies
        • Product Partnering
        • Amneal Research and Technology
  • Investors
        • InvestorsBecome an Informed Investor
        • Financial Reports
          • SEC Filings
          • Annual Reports
          • Quarterly & Other Reports
        • Events & Presentations
        • Stock Information
        • Corporate Governance
          • Policies
          • Executive Officers & Directors
          • Board Committees
        • Investor Resources
          • Analysts
          • Investor FAQ
          • Email Alerts
          • Information Request
          • RSS Feeds
        • Amneal Investors
  • News
  • Careers
        • CareersJoin our quest to make healthy possible
        • Total Rewards
        • Search Our Career Opportunities
        • Amneal Careers
  • Contact
  • Customer Login
Amneal Pharmaceuticals

The Amneal Patient Assistance Program

We help patients in need

Our patient assistance program is just one of the many ways we help patients in need. Since 2012, our patient assistance program has provided free medicines to thousands of eligible patients.

The Amneal Patient Assistance Program offers eligible individuals the opportunity to apply to receive free medication for up to one year of: EMVERM® (mebendazole) chewable tablets and RYTARY® (carbidopa and levodopa).

The Amneal Patient Assistance Program application/instructions and full eligibility requirements and available products are available here.  For questions regarding this program or application, please call us at 1-877-764-9021, Monday through Friday, 8:00 am to 5:00 pm CST.

Emverm® Savings Program
Emverm® Savings Program
MyRytary Patient <br>Support Program
MyRytary Patient
Support Program

 

Other Savings & Support Programs

Amneal also offers savings program for select products as listed below:

  • Abiraterone Acetate Co-Pay Card
  • Emtricitabine and Tenofovir Disoproxil Fumarate Co-Pay Card
  • Emverm® Savings Program
  • Epinephrine Auto-Injector Savings Card
  • MyRytary Patient Support Program
  • RYTARY Co-Pay Card Program
  • Unithroid Savings Program 
  • Vigabatrin Patient Support
  • ZOMIG® Savings Card
  • Privacy Notice
  • Privacy Shield
  • Copyright & Legal Disclaimer
  • Web Accessibility
  • Linkedin
  • NABP DDA Accreditation
© 2021 Amneal Pharmaceuticals LLC.
All rights reserved.
We use cookies for statistical and measurement purposes, to help improve our website and to allow us and our partners to provide you with more relevant information. By continuing
to navigate this site, closing this box, or by clicking here you are indicating your consent to our use of cookies. To find out more, including how to withdraw your consent, click here
ACCEPTREFUSE
Revoke cookies